BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7531709)

  • 21. Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.
    Hartmann R; Justesen J; Sarkar SN; Sen GC; Yee VC
    Mol Cell; 2003 Nov; 12(5):1173-85. PubMed ID: 14636576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interactions between double-stranded RNA and the double-stranded RNA binding domain of the interferon induced protein kinase.
    Patel RC; Sen GC
    Cell Mol Biol Res; 1994; 40(7-8):671-82. PubMed ID: 7787885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of antiviral action of interferon.
    Baglioni C; Nilsen TW
    Interferon; 1983; 5():23-42. PubMed ID: 6202642
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
    McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.
    Vachon VK; Calderon BM; Conn GL
    Nucleic Acids Res; 2015 Jan; 43(1):544-52. PubMed ID: 25477390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution conformation of adenovirus virus associated RNA-I and its interaction with PKR.
    Dzananovic E; Patel TR; Chojnowski G; Boniecki MJ; Deo S; McEleney K; Harding SE; Bujnicki JM; McKenna SA
    J Struct Biol; 2014 Jan; 185(1):48-57. PubMed ID: 24291322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase.
    Galabru J; Katze MG; Robert N; Hovanessian AG
    Eur J Biochem; 1989 Jan; 178(3):581-9. PubMed ID: 2912723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function.
    Ghadge GD; Swaminathan S; Katze MG; Thimmapaya B
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7140-4. PubMed ID: 1714589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA.
    Carpick BW; Graziano V; Schneider D; Maitra RK; Lee X; Williams BR
    J Biol Chem; 1997 Apr; 272(14):9510-6. PubMed ID: 9083092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein.
    Sànchez R; Mohr I
    J Virol; 2007 Apr; 81(7):3455-64. PubMed ID: 17229694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI.
    Clarke PA; Pe'ery T; Ma Y; Mathews MB
    Nucleic Acids Res; 1994 Oct; 22(21):4364-74. PubMed ID: 7971266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain.
    Lee SB; Green SR; Mathews MB; Esteban M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10551-5. PubMed ID: 7937992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
    Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
    J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase.
    Sarkar SN; Bandyopadhyay S; Ghosh A; Sen GC
    J Biol Chem; 1999 Jan; 274(3):1848-55. PubMed ID: 9880569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase.
    Patel RC; Sen GC
    J Biol Chem; 1992 Apr; 267(11):7671-6. PubMed ID: 1373135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase.
    Desai SY; Sen GC
    J Interferon Cytokine Res; 1997 Sep; 17(9):531-6. PubMed ID: 9335430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA.
    Xiao Q; Sharp TV; Jeffrey IW; James MC; Pruijn GJ; van Venrooij WJ; Clemens MJ
    Nucleic Acids Res; 1994 Jul; 22(13):2512-8. PubMed ID: 7518914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Length dependent activation of OAS proteins by dsRNA.
    Wang Y; Holleufer A; Gad HH; Hartmann R
    Cytokine; 2020 Feb; 126():154867. PubMed ID: 31629990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two molecular weight forms of human 2',5'-oligoadenylate synthetase have different activation requirements.
    Ilson DH; Torrence PF; Vilcek J
    J Interferon Res; 1986 Feb; 6(1):5-12. PubMed ID: 3701128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of 2'-5'-oligoadenylate synthetase in gamma-interferon-mediated growth inhibition of A431 cells.
    Kumar R; Mendelsohn J
    Cancer Res; 1989 Sep; 49(18):5180-4. PubMed ID: 2504485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.